Ouabain Octahydrate (Synonyms: Acocantherine; G-Strophanthin)
目录号: PC66795 纯度: ≥99%
CAS No. :11018-89-6
商品编号 规格 价格 会员价 是否有货 数量
PC66795-1mg 1mg 询价 询价
PC66795-100mg 100mg ¥902.50 请登录
PC66795-1mL 1mL ¥522.50 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
Ouabain Octahydrate
中文别名
毒毛旋花苷;十水合乌本苷;2-氧杂-6-氮杂-螺[3,3]庚烷-6-甲酸叔丁酯;4-(2-噻酚基)苯基硼酸;g-Strophanthin Octahydrate g-羊角拗质;g-羊角拗质;毒毛旋花苷G;环已酮;乌本( 箭毒) 苷, 哇巴因;乌本苷;G毒毛旋花苷;哇巴因;乌巴因;乌本(箭毒)苷;羊角拗质;乌本苷八水合物;毒毛旋花苷G (羊角拗质、乌本( 箭毒) 苷、哇巴因、乌本苷、G毒毛旋花苷、乌本苷八水合物);G毒毛旋花苷/乌本苷
英文名称
Ouabain Octahydrate
英文别名
Card-20(22)-enolide,3-[(6-deoxy-a-L-mannopyranosyl)oxy]-1,5,11,14,19-pentahydroxy-,hydrate (1:8), (1b,3b,5b,11a)-;Ouabain octahydrate;Card-20(22)-enolide,3-[(6-deoxy-a-L-mannopyranosyl)oxy]-1,5,11,14,19-pentahydroxy-,hydrate (1:...;OUABAIN OCTAHYDRATE,HPLC;Strophantine Octahydrate;Acocantherine;G-Strophanthin;g-Strophanthin Octahydrate;1β,3β,5β,11α,14,19-Hexahydroxycard-20(22)-enolide 3-(6-deoxy-α-L-mannopyranoside);(1beta,3beta,5beta,11alpha)-3-[(6-Deoxy-alpha-L-mannopyranosyl)oxy]-1,5,11,14,19-pentahydroxy-card-20(22)-enolide octahydrate;OUABAIN 8H2O;OUABAIN 8H20;G-Strophantin;STROPHANTHIN G;OUABAIN HYDRATE;OUBAIN OCTAHYDRATE;(-)-OUABAIN OCTAHYDRATE;Ouabain octahydrate,96%;Ouabain octahydrate 96%;ouabain;Ouabaine;Oubain;Ouabagenin L-rhamnoside;Ouabain anhydrous;Uabanin;Ouabagenin-L-rhamnosid;Purostrophan;Strodival;Gratibain;Astrobain;Acocantherin;Strophanthin-G;Strophalen;Uabaina;Kombetin;Gratus strophanthin;Strophoperm;Strophosan;Solufantina;Rectobaina;G-Strophicor;Quabain;MLS000069786;LPMXVESGRSUGHW-HBYQJFLCSA-N;Ouabain, Octahydrate;5ACL011P69;Ouabagenin-L-rhamnosid [German];SMR000058492
Cas No.
11018-89-6
分子式
C29H44O12
分子量
584.65
包装储存
Powder; -20°C; 3 years; 4°C; 2 years;
生物活性
Ouabain Octahydrate is an inhibitor of Na/K-ATPase, used for the treatment of congestive heart failure.
性状
Solid
体外研究(In Vitro)
Ouabain (100 μM) induces NLRP3 inflammasome activation and IL-1β release in macrophages. Ouabain-induced NLRP3 inflammasome activation is mediated through K efflux. Ouabain (3 nM) alters the expression of EMT markers in NHK and ADPKD cells, and modifies cell-cell adhesion properties in ADPKD. Moreover, ouabain enhances migration of ADPKD cells, selectively modulates tight junctions, and modulates adherens junctions in ADPKD cells in a selective manner. Ouabain also activates TGFβ-Smad3 signaling, alters TER in ADPKD cells. Ouabain (25, 50 or 100 nM) treatment significantly reduces cell proliferation and viability in Raji cells in a dose-dependent manner, with IC50 of 76.48±4.03 nM. Ouabain increases the number of apoptotic cells, induces autophagy, and upregulates Beclin-1 in Raji cells.Medlife has not independently
体内研究(In Vivo)
Ouabain (3 mg/kg) significantly decreases cardiac contractile force with an enlarged LVESD when mice are primed with LPS. IL-1β deficiency attenuates ouabain-induced cardiac dysfunction and injury. IL-1β secreted by infiltrated macrophages contributes to ouabain-induced cardiac inflammation. Deficiency of NLRP3 and Casp1 attenuates ouabain-induced cardiac dysfunction and macrophage infiltration. Ouabain (30 μg/kg, i.p.) modulates ABCB1 activity in thymocytes of Wistar rats and it has the same effect on Swiss mice at 300 μg/kg. After 14 days of ouabain treatment, the MAP of rats is significantly elevated.Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
<
运输条件
Room temperature or refrigerated transport.
储存方式
Powder; -20°C; 3 years; 4°C; 2 years;
结构分类
Steroids
溶解度数据
体外研究:
DMSO : ≥ 125 mg/mL(171.52 mM)
H2O : 10 mg/mL(13.72 mM;ultrasonic and warming and heat to 60°C)
*≥ means soluble, but saturation unknown.
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2